These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 39249542)

  • 1. Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era.
    Li Y; Zhang X; Zou Z; Xiong Y; Gu X; Zou R; Tan J; Zhang L; Zheng Y; Niu T
    Clin Exp Med; 2024 Sep; 24(1):215. PubMed ID: 39249542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review.
    Tang W; Zhang L; Zheng Y; Pan L; Niu T
    Front Oncol; 2024; 14():1286029. PubMed ID: 38333688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.
    Garderet L; Ouldjeriouat H; Bekadja MA; Daguenet E; Bigot N; Vincent L; Roos-Weil D; Vignon M; Ikhlef S; Abraham J; Escoffre-Barbe M; Lioure B; Nacer RA; Lafon I; Mariette C; Karlin L; Morel P; Gilis L; Le Ray E; Blouet A; Nguyen Quoc S; Boffa JJ; Ronco P; Lambert J; Cornillon J
    Br J Haematol; 2024 Apr; 204(4):1450-1458. PubMed ID: 37953476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning.
    Ursu SG; Maples S; Williams KJ; Patrus G; Samhouri Y; Fazal S; Mewawalla P; Sadashiv S
    J Hematol; 2023 Oct; 12(5):201-207. PubMed ID: 37936977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT.
    Waszczuk-Gajda A; Gras L; de Wreede LC; Sirait T; Illes A; Ozkurt ZN; Snowden JA; Arat M; Bulabois CE; Niederland J; Sever M; Paneesha S; Potter V; Gadisseur A; Chalopin T; Van Gorkom G; López JM; Kerre T; Drozd-Sokolowska J; Raj K; Hayden PJ; Beksac M; Yakoub-Agha I; McLornan DP; Schönland S
    Bone Marrow Transplant; 2023 Apr; 58(4):424-429. PubMed ID: 36681775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous stem cell transplantation in multiple myeloma patients with renal impairment.
    Zhai Y; Yan L; Jin S; Yan S; Yao W; Shang J; Shi X; Wang R; Kang H; Lu J; Zhu Z; Tang F; Wei F; Fu C; Wu D
    Ann Hematol; 2023 Mar; 102(3):621-628. PubMed ID: 36633638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option.
    Lazana I; Floro L; Christmas T; Shah S; Bramham K; Cuthill K; Bassett P; Schey S; Kazmi M; Potter V; Pagliuca A; Streetly M; Benjamin R
    Bone Marrow Transplant; 2022 Jun; 57(6):959-965. PubMed ID: 35413986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial.
    Facon T; Kumar SK; Plesner T; Orlowski RZ; Moreau P; Bahlis N; Basu S; Nahi H; Hulin C; Quach H; Goldschmidt H; O'Dwyer M; Perrot A; Venner CP; Weisel K; Mace JR; Raje N; Tiab M; Macro M; Frenzel L; Leleu X; Ahmadi T; Wang J; Van Rampelbergh R; Uhlar CM; Tromp B; Delioukina M; Vermeulen J; Usmani SZ
    Lancet Oncol; 2021 Nov; 22(11):1582-1596. PubMed ID: 34655533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal insufficiency in multiple myeloma: a systematic review and meta-analysis of all randomized trials from 2005-2019.
    Mohyuddin GR; Koehn K; Shune L; Aziz M; Abdallah AO; McClune B; Ganguly S; McGuirk J; Kambhampati S
    Leuk Lymphoma; 2021 Jun; 62(6):1386-1395. PubMed ID: 33416412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure].
    Firsova MV; Mendeleeva LP; Solovev MV; Rekhtina IG; Pokrovskaya OS; Urnova ES; Soboleva NP; Dvirnyk VN; Klyasova GA; Kuzmina LA; Savchenko VG
    Ter Arkh; 2020 Sep; 92(7):70-76. PubMed ID: 33346447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.
    Munn Z; Barker TH; Moola S; Tufanaru C; Stern C; McArthur A; Stephenson M; Aromataris E
    JBI Evid Synth; 2020 Oct; 18(10):2127-2133. PubMed ID: 33038125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment.
    Li H; Yin L; Wang Y; Wang X; Shi M; Cao J; Yan Z; Sang W; Cheng H; Zhu F; Sun H; Li D; Jing G; Zheng J; Li Z; Xu K
    Bone Marrow Transplant; 2020 Nov; 55(11):2215-2218. PubMed ID: 32388534
    [No Abstract]   [Full Text] [Related]  

  • 13. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Impact of Borderline Creatinine Concentration and Glomerular Filtration Rate at Baseline on the Outcome of Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplant.
    Waszczuk-Gajda A; Małyszko J; Vesole DH; Feliksbrot-Bratosiewicz M; Skwierawska K; Krzanowska K; Kobylińska K; Biecek P; Snarski E; Rodziewicz-Lurzyńska A; Kozłowski P; Stefaniak A; Drozd-Sokołowska J; Ziarkiewicz M; Vyas P; Boguradzki P; Mądry K; Biliński J; Tomaszewska A; Maciejewska M; Urbanowska E; Blajer B; Król M; Król M; Zborowska H; Jurczyszyn A; Dwilewicz-Trojaczek J; Jedrzejczak WW; Basak GW
    Transplant Proc; 2020 Sep; 52(7):2186-2192. PubMed ID: 32222395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
    Zhong H; Xie X; Xu G
    Stem Cells Int; 2019; 2019():9401717. PubMed ID: 31781250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras.
    Li AY; Atenafu EG; Bernard RS; Masih-Khan E; Reece D; Franke N; Tiedemann R; Prica A; Trudel S; Kukreti V; Chen CI
    Bone Marrow Transplant; 2020 Mar; 55(3):578-585. PubMed ID: 31558786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
    Ho PJ; Moore EM; McQuilten ZK; Wellard C; Bergin K; Augustson B; Blacklock H; Harrison SJ; Horvath N; King T; Mollee P; Quach H; Reid C; Rosengarten B; Walker P; Wood EM; Spencer A
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e415-e424. PubMed ID: 31208889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.
    Stadtmauer EA; Pasquini MC; Blackwell B; Hari P; Bashey A; Devine S; Efebera Y; Ganguly S; Gasparetto C; Geller N; Horowitz MM; Koreth J; Knust K; Landau H; Brunstein C; McCarthy P; Nelson C; Qazilbash MH; Shah N; Vesole DH; Vij R; Vogl DT; Giralt S; Somlo G; Krishnan A
    J Clin Oncol; 2019 Mar; 37(7):589-597. PubMed ID: 30653422
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.